A Novel Mutation in the VPS13B Gene in a Cohen Syndrome Patient with Positive Antiphospholipid Antibodies
Author(s) -
Roghayeh Dehghan,
Mahdiyeh Behnam,
Alireza Moafi,
Mansoor Salehi
Publication year - 2021
Publication title -
case reports in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 3
eISSN - 2090-6609
pISSN - 2090-6617
DOI - 10.1155/2021/3143609
Subject(s) - medicine , nonsense mutation , microcephaly , antiphospholipid syndrome , pediatrics , nonsense , mutation , antibody , genetics , immunology , gene , missense mutation , biology
Cohen syndrome is an autosomal recessive disorder with the primary symptoms of mental deficiency, progressive retinopathy, hypotonia, microcephaly, obesity of midchildhood onset, intermittent neutropenia, and dysmorphic facial features. The syndrome has high phenotypic heterogeneity and is caused by loss-of-function mutations in the VPS13B gene. Here, we introduce a novel homozygous nonsense mutation (c.8698G > T, p.E2900X) in the VPS13B gene in an 11-year-old Iranian boy with major symptoms of Cohen syndrome. He also had mild anemia accompanied by positive antiphospholipid antibodies, the latter has never been previously reported in Cohen syndrome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom